|
Atherosclerotic disease in the lower limbs, specifically PAD (Peripheral Artery Disease), CLI (Critical Limb Ischemia) and ALI (Acute Limb Ischemia) and diabetic foot ulcer (DFU) form the basis for the current research. PAD is also known as Peripheral Vascular Disease (PVD) or Peripheral Arterial Occlusive Disease (PAOD). Our research provides a comprehensive analysis of the disease including prevalence, risk factors, comorbidities and consequences. Leading drug and device therapies, new technologies and company participants are identified. Competing technologies are assessed in terms of efficacy, cost-effectiveness and other key outcome measures. In the future we will expand our peripheral focus to venous thromboembolic diseases including deep vein thrombosis (DVT) and pulmonary embolism (PE). |
According to Mary L. Yost, “Because of the global epidemic of diabetes and the fact that diabetics represent 60% to 80% of CLI patients, we believe that critical limb ischemia represents a major and significantly underestimated worldwide problem."
|
